Cargando…
Identification and Tracking of Antiviral Drug Combinations
Combination therapies have become a standard for the treatment for HIV and hepatitis C virus (HCV) infections. They are advantageous over monotherapies due to better efficacy, reduced toxicity, as well as the ability to prevent the development of resistant viral strains and to treat viral co-infecti...
Autores principales: | Ianevski, Aleksandr, Yao, Rouan, Biza, Svetlana, Zusinaite, Eva, Männik, Andres, Kivi, Gaily, Planken, Anu, Kurg, Kristiina, Tombak, Eva-Maria, Ustav, Mart, Shtaida, Nastassia, Kulesskiy, Evgeny, Jo, Eunji, Yang, Jaewon, Lysvand, Hilde, Løseth, Kirsti, Oksenych, Valentyn, Aas, Per Arne, Tenson, Tanel, Vitkauskienė, Astra, Windisch, Marc P., Fenstad, Mona Høysæter, Nordbø, Svein Arne, Bjørås, Magnar, Kainov, Denis E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589631/ https://www.ncbi.nlm.nih.gov/pubmed/33080984 http://dx.doi.org/10.3390/v12101178 |
Ejemplares similares
-
The Transcription Map of Human Papillomavirus Type 18 during Genome Replication in U2OS Cells
por: Toots, Mart, et al.
Publicado: (2014) -
Potential Antiviral Options against SARS-CoV-2 Infection
por: Ianevski, Aleksandr, et al.
Publicado: (2020) -
Active Components of Commonly Prescribed Medicines Affect Influenza A Virus–Host Cell Interaction: A Pilot Study
por: Ianevski, Aleksandr, et al.
Publicado: (2021) -
HybriFree: a robust and rapid method for the development of monoclonal antibodies from different host species
por: Kivi, Gaily, et al.
Publicado: (2016) -
Nafamostat–Interferon-α Combination Suppresses SARS-CoV-2 Infection In Vitro and In Vivo by Cooperatively Targeting Host TMPRSS2
por: Ianevski, Aleksandr, et al.
Publicado: (2021)